Tecan accelerates broad genomics strategy with the acquisition of NuGEN Technologies
(WorldNews Switzerland)

August 16, 2018 Acquisition of US-based NuGEN expands Tecan`s dedicated solutions offering into new market segment of next-generation sequencing (NGS) reagents and increases overall recurring revenues NuGEN provides innovative NGS kits and genomic sample prep reagents for the fastest growing field within the genomics area NuGEN to become part of Tecan`s Life Sciences Business, leveraging Tecan`s global presence and strong positionin NGS sample preparation automation platforms Consideration of USD 54.5 million (CHF 54.1 million) representing less than four times expected fiscal year 2018 sales of NuGEN Tecan anticipates to triple NuGEN`s sales by 2023 Total sales of more than CHF 75 million...